Cell-matrix interactions in muscle disease

被引:67
作者
Carmignac, Virginie [1 ]
Durbeej, Madeleine [1 ]
机构
[1] Lund Univ, Dept Expt Med Sci, Muscle Biol Unit, S-22184 Lund, Sweden
关键词
muscle; extracellular matrix; membrane; cytoskeleton; disease; muscular dystrophy; CONGENITAL MUSCULAR-DYSTROPHY; COLLAGEN-VI DEFICIENCY; LAMININ ALPHA-1 CHAIN; BONE-MARROW-TRANSPLANTATION; MYOSTATIN PROPEPTIDE GENE; IMPROVES CARDIAC-FUNCTION; TRANSGENIC MDX MICE; DY(W) MOUSE MODEL; SKELETAL-MUSCLE; STEM-CELLS;
D O I
10.1002/path.3020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The extracellular matrix (ECM) provides a solid scaffold and signals to cells through ECM receptors. The cell-matrix interactions are crucial for normal biological processes and when disrupted they may lead to pathological processes. In particular, the biological importance of ECM-cell membrane-cytoskeleton interactions in skeletal muscle is accentuated by the number of inherited muscle diseases caused by mutations in proteins conferring these interactions. In this review we introduce laminins, collagens, dystroglycan, integrins, dystrophin and sarcoglycans. Mutations in corresponding genes cause various forms of muscular dystrophy. The muscle disorders are presented as well as advances toward the development of treatment. Copyright (C) 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:200 / 218
页数:19
相关论文
共 356 条
[31]   Utrophin: A structural and functional comparison to dystrophin [J].
Blake, DJ ;
Tinsley, JM ;
Davies, KE .
BRAIN PATHOLOGY, 1996, 6 (01) :37-47
[32]   Function and genetics of dystrophin and dystrophin-related proteins in muscle [J].
Blake, DJ ;
Weir, A ;
Newey, SE ;
Davies, KE .
PHYSIOLOGICAL REVIEWS, 2002, 82 (02) :291-329
[33]   Functional improvement of dystrophic muscle by myostatin blockade [J].
Bogdanovich, S ;
Krag, TOB ;
Barton, ER ;
Morris, LD ;
Whittemore, LA ;
Ahima, RS ;
Khurana, TS .
NATURE, 2002, 420 (6914) :418-421
[34]  
BONALDO P, 1989, J BIOL CHEM, V264, P5575
[35]   BETA-SARCOGLYCAN (A3B) MUTATIONS CAUSE AUTOSOMAL RECESSIVE MUSCULAR-DYSTROPHY WITH LOSS OF THE SARCOGLYCAN COMPLEX [J].
BONNEMANN, CG ;
MODI, R ;
NOGUCHI, S ;
MIZUNO, Y ;
YOSHIDA, M ;
GUSSONI, E ;
MCNALLY, EM ;
DUGGAN, DJ ;
ANGELINI, C ;
HOFFMAN, EP ;
OZAWA, E ;
KUNKEL, LM .
NATURE GENETICS, 1995, 11 (03) :266-273
[36]   Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins [J].
Bonuccelli, G ;
Sotgia, F ;
Schubert, W ;
Park, DS ;
Frank, PG ;
Woodman, SE ;
Insabato, L ;
Cammer, M ;
Minetti, C ;
Lisanti, MP .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04) :1663-1675
[37]   Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice [J].
Bonuccelli, Gloria ;
Sotgia, Federica ;
Capozza, Franco ;
Gazzerro, Elisabetta ;
Minetti, Carlo ;
Lisanti, Michael P. .
CELL CYCLE, 2007, 6 (10) :1242-1248
[38]   The recombinant proregion of transforming growth factor beta 1 (Latency-associated peptide) inhibits active transforming growth factor beta 1 in transgenic mice [J].
Bottinger, EP ;
Factor, VM ;
Tsang, MLS ;
Weatherbee, JA ;
Kopp, JB ;
Qian, SW ;
Wakefield, LM ;
Roberts, AB ;
Thorgeirsson, SS ;
Sporn, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5877-5882
[39]   ELECTRON-MICROSCOPIC EVIDENCE FOR A MUCIN-LIKE REGION IN CHICK MUSCLE ALPHA-DYSTROGLYCAN [J].
BRANCACCIO, A ;
SCHULTHESS, T ;
GESEMANN, M ;
ENGEL, J .
FEBS LETTERS, 1995, 368 (01) :139-142
[40]   Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly [J].
Breedveld, G. ;
de Coo, I. F. ;
Lequin, M. H. ;
Arts, W. F. M. ;
Heutink, P. ;
Gould, D. B. ;
John, S. W. M. ;
Oostra, B. ;
Mancini, G. M. S. .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (06) :490-495